GGrantIndex
Sort

17,828 grants matching crispr

Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma

$659,913
Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA

Development and maintenance of chronic toxoplasmosis

$659,753
Sebastian Lourido · Whitehead Institute For Biomedical Res · R01 · FY2023 · AI

Phylogeny, historical biogeography, and floral ecological-evolutionary-developmental studies in Mariposa lilies and relatives (Calochortus, Liliaceae)

$659,707
Thomas J Givnish · University Of Wisconsin-Madison · · FY2019 · BIO

Human iPSC-derived atrial cardiomyocytes to model atrial fibrillation in a dish

$659,665
Dawood Darbar · University Of Illinois At Chicago · R01 · FY2020 · HL

Virus-driven human gene misregulation in disease

$659,545
Matthew Tyson Weirauch · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · HG

Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1

$659,046
Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Metabolic Control of Translation in Glioblastoma

$659,002
Jeremy N Rich · Univ Of North Carolina Chapel Hill · R01 · FY2025 · NS

Targeting ZNF410 for HbF reactivation

$658,954
Daniel Evan Bauer · Boston Children'S Hospital · R01 · FY2024 · HL

Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion

$658,920
Qizhi Tang · University Of California, San Francisco · R01 · FY2024 · DK

Thyroid Hormone Signaling in Human Hepatocytes

$658,627
Anthony N Hollenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DK

Genetic Analysis of Hirschsprung Disease - Renewal

$658,605
Aravinda Chakravarti · New York University School Of Medicine · R01 · FY2023 · HD

Defining molecular pathways triggered by IL-10 and TGFb that drive HIV integration and persistence in Tfh cells in lymph nodes

$658,579
Susan Pereira Ribeiro · Emory University · R01 · FY2025 · AI

Single-Cell Transcriptomics of Non-Activated Latently Infected T cells Isolated from HIV+ Drug Users

$658,493
Melanie Maria Ott · J. David Gladstone Institutes · R61 · FY2021 · DA

Single-Cell Transcriptomics of Non-Activated Latently Infected T cells Isolated from HIV+ Drug Users

$658,493
Melanie Maria Ott · J. David Gladstone Institutes · R61 · FY2020 · DA

Mechanisms and therapeutic implications of human clonal hematopoiesis (CH) mutations

$658,437
Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA

Engineering T Cell Adoptive Therapy for Glioblastoma

$658,407
Gavin Peter Dunn · Massachusetts General Hospital · R01 · FY2023 · NS

Developing Regeneration Resources for a Model Amphibian

$657,943
Stephen Randal Voss · University Of Kentucky · R24 · FY2016 · OD

Killer Archaea: An emergent property of virus-host symbiosis in archaeal cells with active CRISPR-Cas immunity

$657,940
Rachel J Whitaker · University Of Illinois At Urbana-Champaign · · FY2017 · BIO

Collaborative Pathways that Lead to Leukemia

$657,818
Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Escalation in coevolution: Characterization of novel plant toxins, how specialist herbivores cope, and tests of phylogenetic intensification in plant defense potency

$657,747
Anurag Agrawal · Cornell University · · FY2022 · BIO

Evaluating the Functional Impact of Genetic Diversity on Malaria Vaccine Candidates

$657,385
Amy Kristine Bei · Yale University · R01 · FY2024 · AI

Targeting natural killer cells to enhance HIV vaccine responses

$657,254
Stephen N. Waggoner · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · AI

Noninvasive High-Resolution Mapping of HCC Tumor Biology Predictive of Malignancy

$657,105
Kejia Cai · University Of Illinois At Chicago · R01 · FY2024 · CA

Dissecting the role of DNA Ligase 1 in Huntington's disease

$657,103
Vanessa C Wheeler · Massachusetts General Hospital · R01 · FY2025 · NS

Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs

$657,101
Joseph C Wu · Stanford University · R01 · FY2025 · HL